Jefferies Group upgraded shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) from a hold rating to a buy rating in a research report released on Monday. They currently have $95.00 price target on the pharmacy operator’s stock, up from their previous price target of $87.00.

WBA has been the subject of several other reports. Robert W. Baird reiterated an outperform rating and issued a $98.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, June 27th. Evercore ISI restated a buy rating and set a $93.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, July 7th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a sell rating to a hold rating in a report on Tuesday, June 21st. Credit Suisse Group AG restated a buy rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, October 3rd. Finally, Deutsche Bank AG restated a buy rating on shares of Walgreens Boots Alliance in a report on Monday, July 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus price target of $93.35.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up 0.32% during midday trading on Monday, reaching $78.26. The company’s stock had a trading volume of 231,129 shares. The company has a market capitalization of $84.70 billion, a P/E ratio of 27.04 and a beta of 1.01. The stock has a 50 day moving average of $80.79 and a 200-day moving average of $80.97. Walgreens Boots Alliance has a 1-year low of $71.50 and a 1-year high of $95.74.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be issued a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.92%. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance’s payout ratio is 51.90%.

In related news, EVP Kathleen Wilson-Thompson sold 23,996 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $85.00, for a total transaction of $2,039,660.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Foote sold 2,067 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total transaction of $168,150.45. Following the transaction, the director now directly owns 26,690 shares of the company’s stock, valued at $2,171,231.50. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Walgreens Boots Alliance by 2.3% in the second quarter. Vanguard Group Inc. now owns 60,289,046 shares of the pharmacy operator’s stock valued at $5,020,269,000 after buying an additional 1,371,240 shares in the last quarter. State Street Corp increased its position in shares of Walgreens Boots Alliance by 2.1% in the first quarter. State Street Corp now owns 36,198,072 shares of the pharmacy operator’s stock valued at $3,049,327,000 after buying an additional 746,698 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Walgreens Boots Alliance by 9.7% in the first quarter. Wellington Management Group LLP now owns 26,167,061 shares of the pharmacy operator’s stock valued at $2,204,313,000 after buying an additional 2,317,093 shares in the last quarter. BlackRock Institutional Trust Company N.A. increased its position in shares of Walgreens Boots Alliance by 0.7% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 22,365,047 shares of the pharmacy operator’s stock valued at $1,862,337,000 after buying an additional 159,480 shares in the last quarter. Finally, Capital World Investors increased its position in shares of Walgreens Boots Alliance by 11.5% in the second quarter. Capital World Investors now owns 19,625,115 shares of the pharmacy operator’s stock valued at $1,634,183,000 after buying an additional 2,028,252 shares in the last quarter. 59.76% of the stock is owned by hedge funds and other institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.